{"id":800341,"date":"2025-01-14T05:51:09","date_gmt":"2025-01-14T10:51:09","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\/"},"modified":"2025-01-14T05:51:09","modified_gmt":"2025-01-14T10:51:09","slug":"investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\/","title":{"rendered":"Investors in Caribou Biosciences, Inc. Should Contact Levi &amp; Korsinsky Before February 24, 2025 to Discuss Your Rights &#8211; CRBU"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">NEW YORK<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Jan. 14, 2025<\/span><\/span> \/PRNewswire\/ &#8212; Levi &amp;\u00a0Korsinsky, LLP notifies investors in <b>Caribou Biosciences, Inc.<\/b> (&#8220;Caribou Biosciences, Inc.&#8221; or the &#8220;Company&#8221;) (NASDAQ: CRBU) of a class action securities lawsuit.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg\" title=\"Levi &amp; Korsinsky, LLP (PRNewsfoto\/Levi &amp; Korsinsky, LLP)\" alt=\"Levi &amp; Korsinsky, LLP (PRNewsfoto\/Levi &amp; Korsinsky, LLP)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <b>CLASS DEFINITION: <\/b>The lawsuit seeks to recover losses on behalf of Caribou Biosciences, Inc. investors who were adversely affected by <span>alleged<\/span> securities <span>fraud<\/span> between <span class=\"xn-chron\">July 14, 2023<\/span> and <span class=\"xn-chron\">July 16, 2024<\/span>. Follow the link below to get more information and be contacted by a member of our team:<\/p>\n<p class=\"prntac\">\n        <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4339409-11&amp;h=1896931387&amp;u=https%3A%2F%2Fzlk.com%2Fpslra-1%2Fcaribou-biosciences-inc-lawsuit-submission-form%3Fprid%3D122517%26wire%3D4&amp;a=https%3A%2F%2Fzlk.com%2Fpslra-1%2Fcaribou-biosciences-inc-lawsuit-submission-form%3Fprid%3D122517%26wire%3D4\" target=\"_blank\" rel=\"nofollow\">https:\/\/zlk.com\/pslra-1\/caribou-biosciences-inc-lawsuit-submission-form?prid=122517&amp;wire=4<\/a>\n      <\/p>\n<p>\n        <b>CRBU<\/b>\u00a0investors may also contact <span class=\"xn-person\">Joseph E. Levi, Esq.<\/span> via email at\u00a0<a href=\"mailto:jlevi@levikorsinsky.com\" target=\"_blank\" rel=\"nofollow\">jlevi@levikorsinsky.com<\/a>\u00a0or by telephone at (212) 363-7500.<\/p>\n<p>\n        <b>CASE DETAILS: <\/b>The filed complaint <span>alleges<\/span> that defendants made false statements and\/or concealed that: (i) they had overstated CB-010&#8217;s safety, efficacy, and durability relative to approved autologous CAR-T cell therapies in treating patients with r\/r B-NHL and\/or LBCL, as well as CB-010&#8217;s overall clinical results and commercial prospects; (ii) Caribou was at significant risk of having insufficient cash, liquidity, and\/or other capital to fund its current business operations, including preclinical research activities associated with the allogeneic CAR-NK platform; (iii) all the foregoing was likely to have a significant negative impact on Caribou&#8217;s business and operations; and (iv) as a result, defendants&#8217; public statements were materially false and misleading at all relevant times.<\/p>\n<p>\n        <b>WHAT&#8217;S NEXT? <\/b>If you suffered a loss in Caribou Biosciences, Inc. during the relevant time frame, you have until <b><span class=\"xn-chron\">February 24, 2025<\/span><\/b>\u00a0to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn&#8217;t require that you serve as a lead plaintiff.<\/p>\n<p>\n        <b>NO COST TO YOU: <\/b>If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. <b>There is no cost or obligation to participate.<\/b><\/p>\n<p>\n        <b>WHY LEVI &amp; KORSINSKY: <\/b>Over the past 20 years, the team at Levi &amp; Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi &amp; Korsinsky has ranked in ISS Securities Class Action Services&#8217; Top 50 Report as one of the top securities litigation firms in <span class=\"xn-location\">the United States<\/span>.<\/p>\n<p>\n        <b>CONTACT:<\/b><br \/>\n        <br \/>Levi &amp; Korsinsky, LLP <br \/><span class=\"xn-person\">Joseph E. Levi, Esq.<\/span><br \/><span class=\"xn-person\">Ed Korsinsky, Esq.<\/span><br \/>33 Whitehall Street, 17th Floor<br \/><span class=\"xn-location\">New York, NY<\/span> 10004<br \/><a href=\"mailto:jlevi@levikorsinsky.com\" target=\"_blank\" rel=\"nofollow\">jlevi@levikorsinsky.com<\/a><br \/>Tel: (212) 363-7500<br \/>Fax: (212) 363-7171<br \/><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4339409-11&amp;h=3670962740&amp;u=https%3A%2F%2Fwww.zlk.com%2F&amp;a=www.zlk.com\" target=\"_blank\" rel=\"nofollow\">www.zlk.com<\/a><\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY95089&amp;sd=2025-01-14\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/investors-in-caribou-biosciences-inc-should-contact-levi--korsinsky-before-february-24-2025-to-discuss-your-rights--crbu-302349663.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/investors-in-caribou-biosciences-inc-should-contact-levi&#8211;korsinsky-before-february-24-2025-to-discuss-your-rights&#8211;crbu-302349663.html<\/a><\/p>\n<p>SOURCE  Levi &amp; Korsinsky, LLP<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY95089&amp;Transmission_Id=202501140545PR_NEWS_USPR_____NY95089&amp;DateId=20250114\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK , Jan. 14, 2025 \/PRNewswire\/ &#8212; Levi &amp;\u00a0Korsinsky, LLP notifies investors in Caribou Biosciences, Inc. (&#8220;Caribou Biosciences, Inc.&#8221; or the &#8220;Company&#8221;) (NASDAQ: CRBU) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Caribou Biosciences, Inc. investors who were adversely affected by alleged securities fraud between July 14, 2023 and July 16, 2024. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/caribou-biosciences-inc-lawsuit-submission-form?prid=122517&amp;wire=4 CRBU\u00a0investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and\/or concealed that: (i) they had overstated CB-010&#8217;s safety, efficacy, and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Investors in Caribou Biosciences, Inc. Should Contact Levi &amp; Korsinsky Before February 24, 2025 to Discuss Your Rights &#8211; CRBU&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-800341","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Investors in Caribou Biosciences, Inc. Should Contact Levi &amp; Korsinsky Before February 24, 2025 to Discuss Your Rights - CRBU - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Investors in Caribou Biosciences, Inc. Should Contact Levi &amp; Korsinsky Before February 24, 2025 to Discuss Your Rights - CRBU - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK , Jan. 14, 2025 \/PRNewswire\/ &#8212; Levi &amp;\u00a0Korsinsky, LLP notifies investors in Caribou Biosciences, Inc. (&#8220;Caribou Biosciences, Inc.&#8221; or the &#8220;Company&#8221;) (NASDAQ: CRBU) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Caribou Biosciences, Inc. investors who were adversely affected by alleged securities fraud between July 14, 2023 and July 16, 2024. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/caribou-biosciences-inc-lawsuit-submission-form?prid=122517&amp;wire=4 CRBU\u00a0investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and\/or concealed that: (i) they had overstated CB-010&#8217;s safety, efficacy, and &hellip; Continue reading &quot;Investors in Caribou Biosciences, Inc. Should Contact Levi &amp; Korsinsky Before February 24, 2025 to Discuss Your Rights &#8211; CRBU&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-14T10:51:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Investors in Caribou Biosciences, Inc. Should Contact Levi &amp; Korsinsky Before February 24, 2025 to Discuss Your Rights &#8211; CRBU\",\"datePublished\":\"2025-01-14T10:51:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\\\/\"},\"wordCount\":451,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280334\\\/Levi_and_Korsinsky_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\\\/\",\"name\":\"Investors in Caribou Biosciences, Inc. Should Contact Levi &amp; Korsinsky Before February 24, 2025 to Discuss Your Rights - CRBU - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280334\\\/Levi_and_Korsinsky_Logo.jpg\",\"datePublished\":\"2025-01-14T10:51:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280334\\\/Levi_and_Korsinsky_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280334\\\/Levi_and_Korsinsky_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investors in Caribou Biosciences, Inc. Should Contact Levi &amp; Korsinsky Before February 24, 2025 to Discuss Your Rights &#8211; CRBU\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Investors in Caribou Biosciences, Inc. Should Contact Levi &amp; Korsinsky Before February 24, 2025 to Discuss Your Rights - CRBU - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\/","og_locale":"en_US","og_type":"article","og_title":"Investors in Caribou Biosciences, Inc. Should Contact Levi &amp; Korsinsky Before February 24, 2025 to Discuss Your Rights - CRBU - Market Newsdesk","og_description":"PR Newswire NEW YORK , Jan. 14, 2025 \/PRNewswire\/ &#8212; Levi &amp;\u00a0Korsinsky, LLP notifies investors in Caribou Biosciences, Inc. (&#8220;Caribou Biosciences, Inc.&#8221; or the &#8220;Company&#8221;) (NASDAQ: CRBU) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Caribou Biosciences, Inc. investors who were adversely affected by alleged securities fraud between July 14, 2023 and July 16, 2024. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/caribou-biosciences-inc-lawsuit-submission-form?prid=122517&amp;wire=4 CRBU\u00a0investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and\/or concealed that: (i) they had overstated CB-010&#8217;s safety, efficacy, and &hellip; Continue reading \"Investors in Caribou Biosciences, Inc. Should Contact Levi &amp; Korsinsky Before February 24, 2025 to Discuss Your Rights &#8211; CRBU\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\/","og_site_name":"Market Newsdesk","article_published_time":"2025-01-14T10:51:09+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Investors in Caribou Biosciences, Inc. Should Contact Levi &amp; Korsinsky Before February 24, 2025 to Discuss Your Rights &#8211; CRBU","datePublished":"2025-01-14T10:51:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\/"},"wordCount":451,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\/","name":"Investors in Caribou Biosciences, Inc. Should Contact Levi &amp; Korsinsky Before February 24, 2025 to Discuss Your Rights - CRBU - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg","datePublished":"2025-01-14T10:51:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2280334\/Levi_and_Korsinsky_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investors-in-caribou-biosciences-inc-should-contact-levi-korsinsky-before-february-24-2025-to-discuss-your-rights-crbu\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Investors in Caribou Biosciences, Inc. Should Contact Levi &amp; Korsinsky Before February 24, 2025 to Discuss Your Rights &#8211; CRBU"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/800341","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=800341"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/800341\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=800341"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=800341"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=800341"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}